Company-wide revenue
Reported revenue in 2021 ¥560.03B Reported revenue in 2025 ¥453.29B
- growth amount
- −¥106.74B
- growth annualized
- -5.1%
- growth total
- -19.1%
Japanese company profile · 4506
Sumitomo Pharma Co., Ltd.
In its FY2025 public filing, Sumitomo Pharma Co., Ltd. reports Japan, North America, Asia. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 住友ファーマ株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Sumitomo Pharma Co., Ltd.'s largest reported business by revenue in FY2025 was North America.
The business with the highest reported segment profit in FY2025 was North America.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Revenue from external customers | Revenue share | Segment profit (loss) |
|---|---|---|---|
| North America | ¥337.92B ↗ | — | ¥75.74B ↗ |
| Japan | ¥92.36B ↗ | — | ¥12.35B ↗ |
| Asia | ¥23.01B ↗ | — | ¥9.45B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Japan
- 日本
- North America
- 北米
- Asia
- アジア
- China
- 中国
- Overseas and Other Businesses
- 海外その他
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Original Japanese label
- Japan
- 日本
- North America
- 北米
- Asia
- アジア
- China
- 中国
- Overseas and Other Businesses
- 海外その他
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Reported Revenue from external customers by business over time
Reported Revenue from external customers by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Japan | ¥149.91B | ¥126.11B | ¥114.66B | ¥99.84B | ¥92.36B |
| North America | ¥319.79B | ¥328.47B | ¥159.04B | ¥251.81B | ¥337.92B |
| Asia | — | — | ¥40.86B | ¥47.18B | ¥23.01B |
| China | ¥38.3B | ¥39.4B | — | — | — |
| Overseas and Other Businesses | ¥12.18B | ¥16.75B | — | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
North America
Reported revenue in 2021 ¥319.79B Reported revenue in 2025 ¥337.92B
- growth amount
- +¥18.13B
- growth annualized
- +1.4%
- growth total
- +5.7%
View original filing
North America
Reported profit margin in 2022 +9.8%
Reported profit margin in 2025 +22.4%
- growth margin points
- +12.6
View original filing
Japan
Reported profit margin in 2022 +7.2%
Reported profit margin in 2025 +13.4%
- growth margin points
- +6.2
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YH3M
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.